Orchard raises $150m to advance gene therapies
UK-American biotech Orchard Therapeutics has raised $150 million to fuel development of its gene therapy pipeline.
Read More
Tag: OTL-103
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
